Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
Open Access
- 1 August 2001
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 114 (2) , 319-326
- https://doi.org/10.1046/j.1365-2141.2001.02926.x
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase III efficacy study of interleukin‐3 after autologous bone marrow transplantation in patients with malignant lymphomaBritish Journal of Haematology, 1999
- Peripheral blood stem cell transplantation as an alternative to autologous marrow transplantation in the treatment of acute myeloid leukemia?Bone Marrow Transplantation, 1999
- Economic analyses of bone marrow and blood stem cell transplantation for leukemias and lymphoma: what do we know?Bone Marrow Transplantation, 1998
- Salvage chemotherapy with mini-BEAM for relapsed or refractory non-Hodgkin's lymphoma prior to autologous bone marrow transplantationAnnals of Oncology, 1997
- Autologous bone marrow versus non‐mobilized peripheral blood stem cell transplantation for lymphoid malignancies: A prospective, comparative trialAmerican Journal of Hematology, 1997
- Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patientsThe Lancet, 1996
- Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factorBlood, 1993
- Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high-dose chemotherapyBlood, 1993
- Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trialThe Lancet, 1993
- Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non‐hodgkin's lymphoma after failure of the LNH 84 regimenHematological Oncology, 1991